Improved Homing to Bone Marrow, Spleen and Lung of Adoptively Infused NK Cells Expanded Ex Vivo with the Small Molecule Nicotinamide Using Feeder-Free Conditions

Overview
This study demonstrates that nicotinamide (NAM) enhances the homing and retention of NK cells in bone marrow, spleen, and lung. NK cells were expanded in G-Rex® devices under feeder-free conditions with IL-2 or IL-15. The G-Rex® platform supported large-scale expansion, yielding high-purity NK cells.
What this paper found
Culturing donor NK cells with nicotinamide (NAM) in feeder-free conditions improved their homing to bone marrow, spleen and lung after infusion into mice. CD3-depleted apheresis cells were grown for two weeks in G-Rex® devices in medium with human serum and IL-2 or IL-15, with or without 5 mM NAM, without feeder cells or feeding. A large-scale run seeded 3.5 × 10^9 cells and gave about 4-fold total expansion and 50-fold NK expansion, with more than 96% NK cells and under 0.3% T cells. Apart from CD62L, NK phenotype did not differ consistently between expansion methods. In an irradiated NSG myeloma model, mice given tumor cells but no NK cells became paraplegic, so all were sacrificed on day 24.
Note: Preclinical in vitro and mouse work; the authors note that ongoing studies aim to determine the effect of NAM on NK cells cultured with EBV-LCL feeders.
With the exception of CD62L, no consistent differences in the phenotype of NK cells between the various expansion methods were observed — Gabi Frei, Maria Berg, Tony Peled, Robert N. Reger, Ritesh Kotecha, Toshihiro Onishi, Luis Espinoza-Calderon, Nurit Persi, Chana Lador, Amnon Peled, Richard W. Childs
Study details
- Authors
- Gabi Frei, Maria Berg, Tony Peled, Robert N. Reger, Ritesh Kotecha, Toshihiro Onishi, Luis Espinoza-Calderon, Nurit Persi, Chana Lador, Amnon Peled, Richard W. Childs
- Institution
- Gamida-Cell, Jerusalem, Israel · National Heart, Lung & Blood Institute, National Institutes of Health, Bethesda, MD · Goldyne Savad Institute of Gene Therapy, Jerusalem, Israel
- Year
- 2013
- Cell type(s)
- NK Cells
- Application area
- Hematologic malignancy
- Study phase
- Preclinical
How G-Rex® was used
The CD3-depleted fraction of donor apheresis cells was cultured in the G-Rex® gas permeable cell culture device in medium containing HS and IL-2 or IL-15, with or without 5 mM NAM. Cultures ran for two weeks with no feeder cells and no feeding. In the large-scale run, 3.5 × 10^9 cells from 1 × 10^10 collected TNC were seeded, giving about 4-fold total cell expansion (range 2.5-4.9) and 50-fold NK expansion (range 37-87), with more than 96% NK cells and under 0.3% T cells.
Explore related
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.